background
rivalta
test
use
routin
europ
diagnos
felin
infecti
periton
fip
cat
effus
diagnost
accuraci
uncertain
object
object
studi
calcul
sensit
specif
posit
ppv
neg
npv
predict
valu
rivalta
test
fip
identifi
correl
posit
rivalta
test
variabl
measur
effus
fluid
peripher
blood
method
retrospect
studi
medic
record
cat
effus
review
cat
conclus
result
rivalta
test
includ
preval
fip
popul
determin
sensit
specif
ppv
npv
rivalta
test
calcul
variabl
measur
effus
fluid
peripher
blood
compar
cat
posit
neg
rivalta
test
use
mannwhitney
utest
multivari
analysi
result
cat
effus
conclus
posit
neg
result
rivalta
test
definit
final
diagnosi
made
cat
preval
fip
cat
effus
conclus
rivalta
test
result
rivalta
test
sensit
specif
ppv
npv
diagnosi
fip
valu
increas
cat
lymphoma
bacteri
infect
exclud
cat
year
consid
increas
effus
cholesterol
concentr
specif
graviti
well
decreas
serum
albumin
globulin
ratio
hyperbilirubinemia
posit
correl
posit
rivalta
test
result
conclus
sensit
specif
ppv
rivalta
test
diagnosi
fip
lower
previous
report
except
use
young
cat
compon
effus
lead
posit
rivalta
test
remain
unknown
posit
simpli
relat
high
total
protein
concentr
felin
infecti
periton
fip
common
diseas
especi
young
cat
clinic
sign
variabl
depend
organ
affect
often
difficult
make
definit
diagnosi
fip
even
though
mani
test
evalu
blood
bodi
caviti
effus
germani
mani
countri
simpl
assay
term
rivalta
test
perform
effus
cat
suspect
fip
test
develop
italian
physician
fabio
rivalta
publish
report
method
differenti
exud
transud
human
bodi
caviti
effus
sinc
rivalta
test
use
mostli
germani
poland
russia
franc
principl
test
format
precipit
sampl
effus
fluid
ad
solut
acet
acid
test
inexpens
perform
quickli
privat
practic
set
test
longer
use
human
medicin
analyt
method
includ
light
criteria
pleural
lactat
vet
clin
pathol
american
societi
veterinari
clinic
patholog
dehydrogenas
ldh
activ
pleural
fluid
serum
ldh
ratio
pleural
fluid
serum
protein
ratio
replac
cat
test
demonstr
high
sensit
specif
diagnosi
fip
previou
studi
howev
rel
low
number
cat
evalu
dog
rivalta
test
demonstr
diagnost
valu
object
studi
determin
sensit
specif
posit
predict
valu
ppv
neg
predict
valu
npv
rivalta
test
diagnos
fip
larg
cohort
cat
definit
diagnosi
addit
correl
result
rivalta
test
variabl
measur
blood
effus
fluid
investig
studi
conduct
accord
standard
report
diagnost
accuraci
stard
standard
conduct
report
result
studi
diagnost
accuraci
retrospect
analysi
includ
data
cat
effus
present
clinic
small
anim
medicin
ludwig
maximilian
univers
munich
germani
januari
may
age
cat
variabl
measur
blood
effus
fluid
definit
diagnosi
avail
retriev
medic
record
inclus
criteria
presenc
effus
detect
ultrasonograph
examin
perform
rivalta
test
exclus
criterion
question
rivalta
test
result
defin
format
slightli
cloudi
swirl
solut
neither
distinct
dissolut
distinct
precipit
determin
preval
fip
diagnost
accuraci
rivalta
test
cat
definit
diagnosi
includ
figur
correl
rivalta
test
result
variabl
blood
effus
fluid
cat
conclus
posit
neg
rivalta
test
result
includ
figur
definit
diagnosi
fip
either
confirm
posit
immunofluoresc
stain
macrophag
effus
fluid
felin
coronaviru
fcov
antigen
identifi
histolog
chang
diagnost
fip
tissu
immunohistochem
stain
tissu
macrophag
fcov
antigen
postmortem
examin
cat
effus
caus
fip
diagnos
made
echocardiographi
heart
diseas
cytolog
histolog
gross
necropsi
examin
neoplasia
identif
bacteria
cultur
cytolog
examin
bacteri
infect
ultrasonograph
examin
laparotomi
necropsi
cholangiohepat
intussuscept
serum
felin
pancreat
lipas
immunoreact
fpli
concentr
ultrasonograph
examin
laparotomi
necropsi
combin
method
pancreat
histori
anuria
physic
ultrasonograph
examin
uroperitoneum
comparison
pcv
effus
fluid
blood
pcv
fluid
pcv
blood
hemorrhag
dopplerguid
measur
blood
pressur
system
hypertens
diagnosi
fip
made
effus
attribut
diseas
cat
place
fip
group
cat
fip
concurr
diseas
eg
diabet
mellitu
infect
felin
immunodefici
viru
fiv
diseas
specif
evalu
consid
caus
effus
thoracocentesi
abdominocentesi
perform
use
ultrasound
guidanc
often
without
sedat
use
asept
techniqu
butterfli
needl
connect
close
system
use
syring
use
care
collect
ml
effus
fluid
bodi
caviti
fluid
place
tube
contain
edta
plain
serum
tube
sarstedt
ag
co
mbrecht
germani
fluid
analyz
rivalta
test
perform
day
collect
perform
rivalta
test
ml
distil
water
place
plastic
tube
sarstedt
ag
co
one
drop
acet
acid
ad
use
dispos
pipett
merck
darmstadt
germani
solut
mix
thoroughli
use
second
dispos
pipett
drop
effus
fluid
care
place
top
acet
acid
solut
precipit
develop
remain
attach
surfac
retain
shape
slowli
float
bottom
solut
rivalta
test
consid
posit
figur
drop
effus
fluid
dissip
solut
remain
clear
rivalta
test
consid
neg
slightli
cloudi
swirl
appear
neither
form
distinct
precipit
dissip
complet
rivalta
test
consid
question
cat
exclud
studi
analysi
effus
fluid
includ
measur
specif
graviti
sg
refractometri
atago
compani
ltd
tokyo
japan
total
nucleat
cell
count
tncc
red
blood
cell
effus
classifi
accord
sg
tp
concentr
tncc
transud
sg
tp
gl
tncc
modifi
transud
sg
tp
gl
tncc
exud
sg
tp
gl
tncc
fluid
characterist
transud
exud
eg
tp
gl
tncc
also
classifi
modifi
transud
blood
sampl
collect
cephal
saphen
jugular
vein
use
needl
blood
collect
plastic
tube
contain
edta
plastic
serum
tube
without
anticoagul
tube
contain
lithiumheparin
sarstedt
ag
co
analysi
whole
blood
edta
includ
measur
rbc
count
hemoglobin
concentr
hematocrit
hct
white
blood
cell
wbc
count
segment
neutrophil
band
neutrophil
lymphocyt
monocyt
count
celldyn
manual
differenti
count
measur
serum
plasma
includ
concentr
bilirubin
tp
albumin
calcul
globulin
concentr
well
albumin
globulin
g
ratio
urea
diagnost
util
rivalta
test
evalu
calcul
diagnost
sensit
proport
cat
among
cat
fip
posit
rivalta
test
result
diagnost
specif
proport
cat
among
cat
diseas
fip
neg
rivalta
test
result
ppv
probabl
cat
posit
rivalta
test
result
fip
npv
probabl
cat
neg
rivalta
test
result
fip
valu
calcul
cat
definit
diagnosi
subpopul
cat
cat
except
lymphoma
bacteri
infect
diagnos
usual
easili
differenti
fip
cytolog
examin
bacteri
cultur
cat
year
old
cat
fip
young
investig
correl
variabl
measur
effus
fluid
blood
rivalta
test
result
classif
effus
transud
modifi
transud
exud
statist
analys
perform
use
spss
version
spss
inc
chicago
il
usa
base
visual
inspect
boxplot
variabl
normal
distribut
thu
mannwhitney
utest
use
evalu
differ
variabl
measur
effus
fluid
blood
cat
posit
neg
rivalta
test
result
variabl
signific
differ
univari
analysi
found
analyz
multivari
logist
regress
model
use
backward
select
likelihood
ratio
variabl
avail
cat
logist
regress
model
sampl
complet
data
could
analyz
variabl
retain
model
pvalu
signific
variabl
greater
odd
ratio
descript
statist
describ
strength
associ
variabl
vari
base
examin
medic
record
cat
effus
identifi
januari
may
conclus
result
rivalta
test
obtain
cat
figur
definit
diagnosi
made
cat
cat
conclus
rivalta
test
result
tabl
cat
fip
effus
caus
neoplasia
heart
diseas
bacteri
infect
pancreat
cholangiohepat
intussuscept
system
hypertens
hemorrhag
effus
secondari
obstruct
lesion
urinari
tract
effus
cat
could
classifi
transud
modifi
transud
exud
effus
cat
could
classifi
measur
sg
tp
concentr
tncc
avail
figur
effus
rivalta
test
posit
small
percentag
classifi
transud
modifi
transud
exud
effus
rivalta
test
neg
exud
tabl
base
result
cat
definit
diagnosi
preval
fip
studi
popul
sensit
specif
ppv
npv
rivalta
test
diagnosi
fip
calcul
whole
popul
subpopul
figur
tabl
cat
year
conclus
rivalta
test
fip
preval
fip
sensit
ppv
rivalta
test
subgroup
higher
overal
popul
exclus
effus
question
rivalta
test
result
effus
includ
figur
analysi
signific
differ
found
variabl
measur
fluid
blood
cat
posit
vs
neg
rivalta
test
result
tabl
signific
greater
vari
preval
fip
cat
effus
studi
lower
report
previous
sensit
specif
ppv
rivalta
test
diagnosi
fip
also
lower
previous
report
unknown
whether
real
decreas
overal
preval
possibl
fip
primari
differenti
diagnosi
cat
see
text
definit
transud
modifi
transud
exud
base
specif
graviti
total
protein
concentr
total
nucleat
cell
count
effus
caus
effus
rare
young
anim
ppv
rivalta
test
fip
lower
ppv
report
earlier
studi
studi
cat
rivalta
test
posit
rare
diseas
fip
present
studi
includ
larger
number
predict
valu
depend
diseas
preval
may
vari
consider
one
clinic
situat
anoth
thu
lower
preval
fip
studi
explain
lower
ppv
rivalta
test
predict
valu
report
studi
must
interpret
light
popul
evalu
may
assign
clinic
situat
cat
year
ppv
posit
rivalta
test
fip
reach
approxim
owe
higher
preval
fip
popul
although
sensit
rivalta
test
diagnosi
fip
also
lower
previous
report
still
high
addit
npv
also
high
indic
rivalta
test
neg
likelihood
fip
caus
effus
low
mani
signific
differ
among
variabl
rivaltaposit
rivaltaneg
effus
reflect
larg
number
cat
studi
long
assum
posit
rivalta
test
would
depend
tp
concentr
effus
howev
present
studi
neither
tp
globlulin
concentr
rivaltaposit
rivaltaneg
effus
significantli
differ
high
low
tp
concentr
found
rivaltaneg
rivaltaposit
effus
thu
tp
globulin
concentr
appear
major
factor
correl
rivalta
test
result
compon
might
result
format
precipit
studi
human
bodi
caviti
effus
sever
acut
phase
protein
rivaltaposit
precipit
could
identifi
therefor
possibl
protein
fraction
eg
acut
phase
protein
caus
posit
reaction
felin
effus
retrospect
studi
neither
electrophoret
analysi
measur
acut
phase
protein
perform
analys
warrant
futur
prospect
studi
cholesterol
concentr
significantli
higher
rivaltaposit
effus
highest
analyt
cholesterol
concentr
found
use
differenti
transud
exud
human
effus
possibl
degener
cellular
compon
eg
wbc
rbc
fluid
cholesterol
exit
vasculatur
due
increas
capillari
permeabl
vascul
present
studi
rivaltaposit
effus
classifi
exud
cholesterol
concentr
increas
exud
thu
cholesterol
concentr
may
higher
rivaltaposit
effus
howev
remain
unknown
whether
cholesterol
caus
contribut
precipit
form
posit
rivalta
test
interestingli
triglycerid
concentr
lower
rivaltaposit
effus
rivaltaneg
effus
triglycerid
may
follow
pattern
cholesterol
shown
mice
fed
cholesterol
high
cholesterol
concentr
actual
decreas
product
triglycerid
format
pseudochyl
typic
contain
cholesterol
triglycerid
occur
longstand
effus
sg
depend
concentr
tp
analyt
effus
variabl
differ
rivaltaposit
rivaltaneg
effus
multivari
analysi
cat
rivaltaposit
effus
significantli
lower
serum
g
ratio
associ
high
globulin
low
albumin
concentr
hypoalbuminemia
may
caus
reduc
hepat
product
like
caus
vascul
decreas
albumin
also
may
reflect
compens
increas
globulin
product
albumin
also
act
neg
acut
phase
protein
cat
fip
could
therefor
downregul
immun
system
serum
bilirubin
concentr
highest
blood
variabl
markedli
higher
cat
rivaltaposit
effus
possibl
due
high
percentag
cat
fip
hyperbilirubinemia
absenc
increas
hepat
enzym
activ
often
occur
suggest
cytokin
releas
fip
affect
bilirubin
metabol
result
alter
excret
biliari
system
cytokin
affect
degrad
bilirubin
reduc
transport
gene
express
directli
inhibit
transport
protein
function
hepatocyt
consequ
hyperbilirubinemia
vet
clin
pathol
american
societi
veterinari
clinic
patholog
bilirubin
concentr
may
also
increas
fip
secondari
immunemedi
hemolysi
hemolysi
caus
dissemin
intravascular
coagul
hepat
involv
cholestasi
studi
sever
limit
retrospect
analysi
variabl
measur
everi
cat
rivalta
test
subject
assay
avail
refer
method
assess
perform
addit
long
investig
period
turnov
laboratori
personnel
perform
test
may
sourc
bia
cat
diagnos
fip
fip
possibl
concurr
diseas
often
investig
hand
although
unlik
cat
fip
may
second
diseas
might
result
effus
measur
blood
analyt
includ
protein
perform
serum
plasma
depend
avail
specimen
could
mask
differ
result
fibrinogen
protein
involv
coagul
present
serum
remain
present
plasma
conclus
rivalta
test
valuabl
diagnost
aid
evalu
felin
effus
fip
ppv
good
npv
excel
compon
effus
lead
posit
rivalta
test
result
elucid
cat
along
electrophoresi
effus
analysi
globulin
fraction
analysi
precipit
form
posit
test
import
next
step
disclosur
author
indic
affili
financi
involv
organ
entiti
financi
interest
financi
competit
subject
matter
materi
discuss
articl
